{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T00:34:55Z","timestamp":1789259695468,"version":"build-2803163510"},"reference-count":200,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Vascular Surgery"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1053\/j.semvascsurg.2022.02.007","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T11:23:37Z","timestamp":1645183417000},"page":"16-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review"],"prefix":"10.1053","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-5531","authenticated-orcid":false,"given":"Robert C.F.","family":"Pena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion A.","family":"Hofmann Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kline-Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenney","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novelett E.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Howitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo T.","family":"S\u00f6derlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaf","family":"Rabin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattie","family":"Boehler-Tatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Marie","family":"Drudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maisoon D.","family":"Yousif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Hoffstaetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Taubenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanth","family":"Vemulapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisanne S.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Rusche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.F.","family":"Pena\u202f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas F.","family":"Mussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"MacCarrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Earl","family":"Goldsborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christeen","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas J.","family":"Mouawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eanas S.","family":"Yassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani","family":"Politano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Teindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith Ford","family":"O'Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Grima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Masciale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeyoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Arnaoutakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejah","family":"Judelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"D'Oria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"del Rio-Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ajalat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie D.","family":"Talutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max V.","family":"Wohlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeniann A.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Eagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion A. Hofmann","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kline-Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyein","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Henoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Damrauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana O.","family":"Afifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana C.","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Estrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery M","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna M.","family":"Milewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth K.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harleen","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akili","family":"Smith-Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L'Oreal","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah O.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenney R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamanna","family":"Nishath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Segal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherene","family":"Shalhub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linell","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Ilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0001","doi-asserted-by":"crossref","unstructured":"Melo RGE, Goncalo SD, Lopes A, et al. Incidence and prevalence of thoracic aortic aneurysms: a systematic review and meta-analysis of population-based studies [published online ahead of print March 8, 2021]. Semin Thorac Cardiovasc Surg doi:10.1053\/j.semtcvs.2021.02.029","DOI":"10.1053\/j.semtcvs.2021.02.029"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0002","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41569-020-00472-6","article-title":"Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes","volume":"18","author":"Bossone","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0003","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0002-9149(00)80066-1","article-title":"Life expectancy in the Marfan syndrome","volume":"75","author":"Silverman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0004","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-med-100415-022956","article-title":"Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: insights from predisposing genes and mouse models","volume":"68","author":"Milewicz","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0005","unstructured":"Aortic Dissection Collaborative for Patient-Centered Research. Engaging Patients with Aortic Dissections as Partners in Patient Centered Outcomes Research: Survey of the Aortic Dissection Community. Patient Centered Outcomes Research Institute. Accessed February 28, 2022. Available at: https:\/\/www.pcori.org\/research-results\/2019\/engaging-patients-type-b-aortic-dissections-partners-patient-centered-outcomes-research"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0006","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2010.02.010","article-title":"2010 ACCF\/AHA\/AATS\/ACR\/ASA\/SCA\/SCAI\/SIR\/STS\/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary","volume":"55","author":"Hiratzka","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0007","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehu281","article-title":"2014 ESC guidelines on the diagnosis and treatment of aortic diseases","volume":"35","author":"Erbel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ppedcard.2012.05.002","article-title":"The 2010 AHA\/ACC\/AATS guidelines on the management of thoracic aortic disease: what they say and why","volume":"34","author":"Buckvold","year":"2012","journal-title":"Prog Pediatr Cardiol"},{"issue":"3 suppl","key":"10.1053\/j.semvascsurg.2022.02.007_bib0009","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jtcvs.2012.11.062","article-title":"Medical management of thoracic aortic aneurysm disease","volume":"145","author":"Braverman","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0010","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/jch.13556","article-title":"Poor management of hypertension is an important precipitating factor for the development of acute aortic dissection","volume":"21","author":"Dong","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0011","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40256-021-00472-y","article-title":"Medical therapies for Marfan syndrome and other thoracic aortic dilatation in adults: a contemporary review","volume":"21","author":"Kocyigit","year":"2021","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0012","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilation and the benefit of long-term beta-adrenergic blockage in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0013","doi-asserted-by":"crossref","first-page":"45","DOI":"10.12945\/j.aorta.2013.13.002","article-title":"Do \u03b2-blockers really work for the prevention of aortic aneurysms?","volume":"1","author":"Chun","year":"2013","journal-title":"Aorta"},{"issue":"4","key":"10.1053\/j.semvascsurg.2022.02.007_bib0014","doi-asserted-by":"crossref","DOI":"10.2174\/1573403X16999201102213619","article-title":"\u0392-blockers and abdominal aortic aneurysm growth: a systematic review and meta-analysis","volume":"17","author":"Siordia","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jvs.2016.06.111","article-title":"Effect of \u03b2-blocker on aneurysm sac behavior after endovascular abdominal aortic repair","volume":"65","author":"Kim","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0016","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1510\/icvts.2010.239764","article-title":"Is close radiographic and clinical control after repair of acute type A aortic dissection really necessary for improved long-term survival?","volume":"11","author":"Albrecht","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0017","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejvs.2020.10.020","article-title":"Celiprolol treatment in patients with vascular Ehlers-Danlos Syndrome","volume":"61","author":"Baderkahn","year":"2021","journal-title":"Eur J Endovasc Surg"},{"issue":"9751","key":"10.1053\/j.semvascsurg.2022.02.007_bib0018","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(10)60960-9","article-title":"Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial","volume":"376","author":"Ong","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0019","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00380-014-0486-7","article-title":"Lower heart rate in the early postoperative period does not correlate with long-term outcomes after repair of type A acute aortic dissection","volume":"30","author":"Ohnuma","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0020","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.drudis.2014.09.022","article-title":"Angiotensin receptor blockers: a panacea for Marfan syndrome and related disorders?","volume":"20","author":"Loeys","year":"2015","journal-title":"Drug Discovery Today"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0021","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10557-020-07116-4","article-title":"Transforming growth factor-\u03b2 and the renin-angiotensin system in syndromic thoracic aortic aneurysms: implications for treatment","volume":"35","author":"van Dorst","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0022","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2016.04.186","article-title":"The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials","volume":"217","author":"Gao","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0024","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjcard.2020.04.034","article-title":"Meta-analysis examining the usefulness of angiotensin receptor blockers for the prevention of aortic root dilation in patients with the Marfan Syndrome","volume":"128","author":"Al-Abcha","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0025","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1093\/eurheartj\/ehaa377","article-title":"Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial","volume":"41","author":"van Andel","year":"2020","journal-title":"Eur Heart J"},{"issue":"10216","key":"10.1053\/j.semvascsurg.2022.02.007_bib0026","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(19)32518-8","article-title":"Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial","volume":"394","author":"Mullen","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0027","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ahj.2015.01.011","article-title":"Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: a report from the Marfan Treatment Trialists\u2019 Collaboration","volume":"169","author":"Pitcher","year":"2015","journal-title":"Am Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0028","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/joim.12958","article-title":"Lack of an effective drug therapy for abdominal aortic aneurysm","volume":"288","author":"Golledge","year":"2020","journal-title":"J Intern Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cjca.2015.11.003","article-title":"Recent clinical drug trials evidence in marfan syndrome and clinical implications","volume":"32","author":"Singh","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/humu.22977","article-title":"Marfan syndrome and related disorders: 25 years of gene discovery","volume":"37","author":"Verstraeten","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0031","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/jamacardio.2019.1176","article-title":"Update on clinical trials of losartan with and without \u03b2-blockers to block aneurysm growth in patients with Marfan syndrome: a review","volume":"4","author":"Hofmann Bowman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0032","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/eurheartj\/ehv575","article-title":"Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial","volume":"37","author":"Forteza","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0033","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.jacc.2018.07.052","article-title":"Losartan versus atenolol for prevention of aortic dilation in patients with Marfan syndrome","volume":"72","author":"Teixido-Tura","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0034","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Atenolol versus losartan in children and young adults with Marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to \u03b2-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0036","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semvascsurg.2022.02.007_bib0037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0469","article-title":"Association of long-term use of antihypertensive medications with late outcomes among patients with aortic dissection","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0038","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.amjcard.2020.12.050","article-title":"Effect of losartan or atenolol on children and young adults with bicuspid aortic valve and dilated aorta","volume":"144","author":"Flyer","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0039","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/00015385.2017.1314134","article-title":"Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial","volume":"72","author":"Mui\u00f1o-Mosquera","year":"2017","journal-title":"Acta Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0040","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","article-title":"Marfan Sartan: a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Milleron","year":"2015","journal-title":"Eur. Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0041","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1093\/eurheartj\/ehz746.0154","article-title":"Losartan vs nebivolol vs the association of both on the progression of aortic root dilation in genotyped Marfan syndrome: 48 months open label randomized controlled phase III trial","volume":"40","author":"Di Toro","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0042","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jfma.2019.03.018","article-title":"The effects of losartan versus \u03b2-blockers on cardiovascular protection in marfan syndrome: a systematic review and meta-analysis","volume":"119","author":"Kang","year":"2020","journal-title":"J Formosan Med Assoc"},{"issue":"1","key":"10.1053\/j.semvascsurg.2022.02.007_bib0043","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/chd.12184","article-title":"The effect of angiotensin-converting enzyme inhibitors on the rate of ascending aorta dilation in patients with bicuspid aortic valve","volume":"10","author":"Ohnemus","year":"2015","journal-title":"Congenit Heart Dis"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0044","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3349\/ymj.2016.57.1.81","article-title":"The beneficial effect of renin-angiotensin-aldosterone system blockade in Marfan syndrome patients after aortic root replacement","volume":"57","author":"Lee","year":"2016","journal-title":"Yonsei Med J"},{"issue":"59","key":"10.1053\/j.semvascsurg.2022.02.007_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20590","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo-controlled trial (AARDVARK)","volume":"20","author":"Kiru","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0046","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/eurheartj\/ehw257","article-title":"An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK)","volume":"37","author":"Bicknell","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvs.2010.02.264","article-title":"Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms","volume":"52","author":"Sweeting","year":"2010","journal-title":"J Vasc Surg"},{"issue":"9536","key":"10.1053\/j.semvascsurg.2022.02.007_bib0048","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(06)69250-7","article-title":"Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study","volume":"368","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0049","doi-asserted-by":"crossref","first-page":"e08648","DOI":"10.7554\/eLife.08648","article-title":"A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome","volume":"4","author":"Doyle","year":"2015","journal-title":"Elife"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0050","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.jvs.2011.12.075","article-title":"Calcium channel blockers enhance sac shrinkage after endovascular aneurysm repair","volume":"55","author":"Bailey","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0051","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000492577","article-title":"Nitrosonifedipine, a photodegradation product of nifedipine, suppresses pharmacologically induced aortic aneurysm formation","volume":"102","author":"Imanishi","year":"2018","journal-title":"Pharmacology"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0052","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","volume":"8","author":"Franken","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0053","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2020.03.064","article-title":"Variants in ADRB1 and CYP2C9: Association with response to atenolol and losartan in Marfan Syndrome","volume":"222","author":"van Driest","year":"2020","journal-title":"J Pediatr"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0054","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jtcvs.2011.12.038","article-title":"Angiotensin-converting enzyme insertion\/deletion polymorphism is a risk factor to thoracic aortic aneurysm in patients with bicuspid or tricuspid aortic valves","volume":"144","author":"Foffa","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2147\/VHRM.S24473","article-title":"Predictors of poor blood pressure control assessed by 24-hour monitoring in patients with type B acute aortic dissection","volume":"8","author":"Delsart","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0056","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2310\/JIM.0b013e318297d0f9","article-title":"Long-term outcome of patients with aortic aneurysms taking low-dose aspirin: a population-based cohort study","volume":"61","author":"Chen","year":"2013","journal-title":"J Invest Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0057","first-page":"450","article-title":"The effect of ticagrelor on growth of small abdominal aortic aneurysms-a randomized controlled trial","volume":"116","author":"Wanhainen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0058","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jvs.2013.11.006","article-title":"Effect of antifibrinolytic therapy with tranexamic acid on abdominal aortic aneurysm shrinkage after endovascular repair","volume":"59","author":"Aoki","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0059","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejvs.2013.12.009","article-title":"Safety of chronic anticoagulation therapy after endovascular abdominal aneurysm repair (EVAR)","volume":"47","author":"de Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0060","first-page":"2321","article-title":"Safety and necessity of antiplatelet therapy on patients underwent endovascular aortic repair with both Stanford Type B aortic dissection and coronary heart disease","volume":"130","author":"He","year":"2017","journal-title":"China Med J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0061","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.2174\/1381612823666171115100829","article-title":"Statins in aortic disease","volume":"23","author":"Tsigkou","year":"2018","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0062","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0003319716637792","article-title":"Lipoprotein(a) levels in patients with abdominal aortic aneurysm","volume":"68","author":"Kotani","year":"2017","journal-title":"Angiology"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0063","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ahj.2009.11.016","article-title":"Association of statin prescription with small abdominal aortic aneurysm progression","volume":"159","author":"Ferguson","year":"2010","journal-title":"Am Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0064","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1024\/0301-1526\/a000161","article-title":"Reduction of small infrarenal abdominal aortic aneurysm expansion rate by statins","volume":"41","author":"Periard","year":"2012","journal-title":"Vasa"},{"issue":"19","key":"10.1053\/j.semvascsurg.2022.02.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008657","article-title":"Statins reduce abdominal aortic aneurysm growth, rupture, and perioperative mortality: a systematic review and meta-analysis","volume":"7","author":"Salata","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0066","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijcard.2015.05.001","article-title":"Effects of statin therapy on ascending aorta aneurysms growth: a propensity-matched analysis","volume":"191","author":"Angeloni","year":"2015","journal-title":"Int J Cardiol"},{"issue":"19","key":"10.1053\/j.semvascsurg.2022.02.007_bib0067","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009866","article-title":"Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: outcomes from the FAME -2 trial","volume":"7","author":"Pinchbeck","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0068","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/1389450119666171227224655","article-title":"Fenofibrate and telmisartan in the management of abdominal aortic aneurysm","volume":"19","author":"Rowbotham","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0069","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jvs.2013.07.026","article-title":"Statin therapy is associated with improved survival after endovascular and open aneurysm repair","volume":"59","author":"de Bruin","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0070","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/1358863X17724221","article-title":"Beneficial effect of statins on total mortality in abdominal aortic aneurysm (AAA) repair","volume":"22","author":"Mathisen","year":"2017","journal-title":"Vasc Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0071","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1177\/1708538114552837","article-title":"The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes","volume":"23","author":"Gali\u00f1anes","year":"2015","journal-title":"Vascular"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0072","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jvs.2021.06.033","article-title":"Statins reduce mortality after abdominal aortic aneurysm repair: a systematic review and meta-analysis","volume":"75","author":"Xiong","year":"2022","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0073","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.avsg.2020.03.036","article-title":"Effect of statin therapy on abdominal aortic aneurysm growth rate and mortality: a systematic review and meta-analysis","volume":"67","author":"Pan","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0074","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejvs.2020.08.007","article-title":"Editor's choice - effect of statins on total mortality in abdominal aortic aneurysm repair: a systematic review and meta-analysis","volume":"61","author":"Risum","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0075","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00268-014-2858-7","article-title":"Effect of lipid-modifying therapy on long-term mortality after abdominal aortic aneurysm repair: a systemic review and meta-analysis","volume":"39","author":"Zhang","year":"2015","journal-title":"World J Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0076","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/FJC.0000000000000653","article-title":"Relationships of statin therapy and hyperlipidemia with the incidence, rupture, postrepair mortality, and all-cause mortality of abdominal aortic aneurysm and cerebral aneurysm: a meta-analysis and systematic review","volume":"73","author":"Cheng","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0077","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jvs.2014.03.280","article-title":"Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection","volume":"60","author":"Tazaki","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0078","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.amjcard.2011.11.038","article-title":"Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug","volume":"109","author":"Jovin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0079","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.amjcard.2013.05.081","article-title":"Effect of statin drugs on thoracic aortic aneurysms","volume":"112","author":"Stein","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0080","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1053\/j.semtcvs.2018.07.019","article-title":"Preoperative statin use not associated with improved outcomes after ascending aortic repair","volume":"30","author":"Tyerman","year":"2018","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0081","doi-asserted-by":"crossref","first-page":"836","DOI":"10.23736\/S0021-9509.18.10463-0","article-title":"Effects of chronic statin use on 30-day major adverse cardiac and cerebrovascular events after thoracic endovascular aortic repair","volume":"59","author":"Ham","year":"2018","journal-title":"J Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0082","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jvs.2011.12.040","article-title":"Statin therapy is associated with aneurysm sac regression after endovascular aortic repair","volume":"55","author":"Raux","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0083","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1538574413513846","article-title":"Statins promote residual aneurysm sac regression following endovascular aortic aneurysm repair","volume":"48","author":"Gray","year":"2014","journal-title":"Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0084","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jvir.2016.09.010","article-title":"Influence of statin therapy on aneurysm sac regression after endovascular aortic repair","volume":"28","author":"Kim","year":"2017","journal-title":"J Vasc Intervent Radiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0085","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/bjs.9895","article-title":"Multicentre study of abdominal aortic aneurysm measurement and enlargement","volume":"102","author":"Lederle","year":"2015","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0086","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.avsg.2020.06.039","article-title":"Metformin prescription associated with reduced abdominal aortic aneurysm growth rate and reduced chemokine expression in a Swedish cohort","volume":"70","author":"Unosson","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0087","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jvs.2016.02.020","article-title":"Metformin treatment status and abdominal aortic aneurysm disease progression","volume":"64","author":"Fujimura","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0088","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejvs.2018.07.035","article-title":"Editor's choice \u2013 metformin prescription is associated with a reduction in the combined incidence of surgical repair and rupture related mortality in patients with abdominal aortic aneurysm","volume":"57","author":"Golledge","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0089","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jvs.2017.01.070","article-title":"Metformin treatment does not affect the risk of ruptured abdominal aortic aneurysms","volume":"66","author":"Kristensen","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0090","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jvs.2018.06.194","article-title":"Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population","volume":"69","author":"Itoga","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0091","doi-asserted-by":"crossref","unstructured":"Golledge J, Arnott C, Moxon J, et al. Protocol for the metformin aneurysm trial (MAT): a placebo-controlled randomized trial testing whether metformin reduces the risk of serious complications of abdominal aortic aneurysm 2020. Australian Clinical Trials. Accessed February 1, 2022. Available at: https:\/\/www.australianclinicaltrials.gov.au\/anzctr\/trial\/ACTRN12618001707257","DOI":"10.1186\/s13063-021-05915-0"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0092","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00595-015-1287-z","article-title":"Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats","volume":"46","author":"Yu","year":"2016","journal-title":"Surg Today"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0093","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/1570161116666180828155622","article-title":"Diabetes, incretin therapy and thoracic aortic aneurysm - what does the evidence show?","volume":"17","author":"Krizhanovskii","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0094","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.amjmed.2004.09.015","article-title":"Fluoroquinolone prescribing in the United States: 1995 to 2002","volume":"118","author":"Linder","year":"2005","journal-title":"Am J Med"},{"issue":"9781849841191","key":"10.1053\/j.semvascsurg.2022.02.007_bib0095","first-page":"264","article-title":"Cardiovascular side-effects of common antibiotics","volume":"2020","author":"Amati","year":"2020","journal-title":"Eur Respir Soc Monogr"},{"issue":"9","key":"10.1053\/j.semvascsurg.2022.02.007_bib0096","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2018.1804","article-title":"Effect of ciprofloxacin on susceptibility of aortic dissection and rupture in mice","volume":"153","author":"LeMaire","year":"2018","journal-title":"JAMA Surg"},{"issue":"11","key":"10.1053\/j.semvascsurg.2022.02.007_bib0097","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010077","article-title":"Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study","volume":"5","author":"Daneman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0098","first-page":"360","article-title":"Fluoroquinolone use and risk of aortic aneurysm and dissection: nationwide cohort study","author":"Pasternak","year":"2018","journal-title":"BMJ"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0099","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacc.2018.06.067","article-title":"Oral fluoroquinolone and the risk of aortic dissection","volume":"72","author":"Lee","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jamasurg.2020.6165","article-title":"Association of fluoroquinolone use with short-term risk of development of aortic aneurysm","volume":"156","author":"Newton","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0101","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/jamainternmed.2020.4199","article-title":"Association of fluoroquinolones with the risk of aortic aneurysm or aortic dissection","volume":"180","author":"Gopalakrishnan","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1053\/j.semvascsurg.2022.02.007_bib0102","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1038\/s41598-020-61717-5","article-title":"Higher admission rates and in-hospital mortality for acute type A aortic dissection during influenza season: a single center experience","volume":"10","author":"Ashur","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0103","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2013.279206","article-title":"Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis","volume":"310","author":"Udell","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.semvascsurg.2022.02.007_bib0104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255887","article-title":"Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: retrospective analyses of three large healthcare databases in the US","volume":"16","author":"Londhe","year":"2021","journal-title":"PLoS One"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1871525717666190402121958","article-title":"Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: a systematic review and meta-analysis","volume":"17","author":"Rawla","year":"2019","journal-title":"Cardiovasc Hematol Agents Med Chemistry"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ijcard.2018.09.067","article-title":"Fluoroquinolones and the risk of aortopathy: A systematic review and meta-analysis","volume":"274","author":"Noman","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0107","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12872-020-01354-y","article-title":"Relationship between fluoroquinolones and the risk of aortic diseases: a meta-analysis of observational studies","volume":"20","author":"Dai","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0108","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.jacc.2021.02.047","article-title":"Effects of fluoroquinolones on outcomes of patients with aortic dissection or aneurysm","volume":"77","author":"Chen","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.semvascsurg.2022.02.007_bib0109","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.semtcvs.2020.11.011","article-title":"Fluoroquinolones are associated with increased risk of aortic aneurysm or dissection: systematic review and meta-analysis","volume":"33","author":"Vouga Ribeiro","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0110","unstructured":"Hunt A. FDA in Brief: FDA warns that fluoroquinolone antibiotics can cause aortic aneurysm in certain patients. FDA. Accessed December 12, 2021. Available at: https:\/\/www.fda.gov\/news-events\/fda-brief\/fda-brief-fda-warns-fluoroquinolone-antibiotics-can-cause-aortic-aneurysm-certain-patients"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0111","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jvs.2016.08.003","article-title":"Challenges and opportunities in limiting abdominal aortic aneurysm growth","volume":"65","author":"Golledge","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0112","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/157016111796197288","article-title":"Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature","volume":"9","author":"Dodd","year":"2011","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0113","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0114","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1024\/0301-1526\/a000388","article-title":"Medical management of abdominal aortic aneurysms","volume":"43","author":"Weiss","year":"2014","journal-title":"Vasa"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/heartjnl-2020-318192","article-title":"Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis","volume":"107","author":"Golledge","year":"2021","journal-title":"Heart"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0116","unstructured":"EU Clinical Trials Register. EudraCT Number 2010-023612-14. A randomized, double-blind placebo-controlled pilot trial of irbesartan, doxycycline, and a combination of markers of vascular dysfunction in Marfan syndrome, using cardiovascular magnetic resonance imaging. March 8, 2013. Accessed December 12, 2021. Available at: Clinical Trials register - Search for eudract_number:2010-023612-14"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jss.2013.11.1105","article-title":"Antioxidant Vitamin C attenuates experimental abdominal aortic aneurysm development in an elastase-induced rat model","volume":"188","author":"Shang","year":"2014","journal-title":"J Surg Res"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0118","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2174\/1389450118666170918164601","article-title":"Abdominal aortic aneurysm (AAA): Is there a role for the prevention and therapy using antioxidants?","volume":"19","author":"Pincemail","year":"2018","journal-title":"Curr Drug Targets"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0119","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/j.jss.2011.07.041","article-title":"Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development","volume":"171","author":"Palmieri","year":"2011","journal-title":"J Surg Res"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCRESAHA.118.312439","article-title":"Pharmacologic management of aneurysms","volume":"124","author":"Lindeman","year":"2019","journal-title":"Circ Res"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0121","first-page":"358","article-title":"Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants","volume":"19","author":"Baradaran","year":"2014","journal-title":"J R Med Sci"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2017.02.001","article-title":"Abdominal aortic aneurysm and omega-3 polyunsaturated fatty acids: mechanisms, animal models, and potential treatment","volume":"118","author":"Meital","year":"2017","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"11","key":"10.1053\/j.semvascsurg.2022.02.007_bib0123","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2174\/1389450118666171013101815","article-title":"Drug therapy for abdominal aortic aneurysms utilizing omega-3 unsaturated fatty acids and their derivatives","volume":"19","author":"Akagi","year":"2018","journal-title":"Current Drug Targets"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0124","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejvs.2013.03.015","article-title":"Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship?","volume":"45","author":"Wong","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"19","key":"10.1053\/j.semvascsurg.2022.02.007_bib0125","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.3390\/ijms20194907","article-title":"Vitamin D as a protector of arterial health: potential role in peripheral arterial disease formation","volume":"20","author":"Krishna","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"43","key":"10.1053\/j.semvascsurg.2022.02.007_bib0126","doi-asserted-by":"crossref","first-page":"E1273","DOI":"10.1503\/cmaj.180510","article-title":"Oral curcumin in elective abdominal aortic aneurysm repair: a multicentre randomized controlled trial","volume":"190","author":"Garg","year":"2018","journal-title":"CMAJ"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0127","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2018.00033","article-title":"Chinese herbal medicine as a potential treatment of abdominal aortic aneurysm","volume":"5","author":"Seto","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0128","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1358863X19829226","article-title":"Association of Life's Simple 7 with reduced clinically manifest abdominal aortic aneurysm: the ARIC study","volume":"24","author":"Oyenuga","year":"2019","journal-title":"Vasc Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.atherosclerosis.2017.04.007","article-title":"Circulating cadmium concentration and risk of aortic aneurysms: a nested case-control study within the Malmo Diet and Cancer cohort","volume":"261","author":"Fagerberg","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00423-016-1401-8","article-title":"Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology","volume":"401","author":"Schmitz-Rixen","year":"2016","journal-title":"Langenbecks Arch Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0131","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jvs.2016.08.091","article-title":"Decreasing prevalence of abdominal aortic aneurysm and changes in cardiovascular risk factors","volume":"65","author":"Persson","year":"2017","journal-title":"J Vasc Surg"},{"issue":"suppl 1","key":"10.1053\/j.semvascsurg.2022.02.007_bib0132","first-page":"98","article-title":"Mediterranea diet and DASH diet can be protective for ascending aortic aneurysm","volume":"24","author":"Kuyumcu","year":"2020","journal-title":"Anatol J Cardiol"},{"issue":"7","key":"10.1053\/j.semvascsurg.2022.02.007_bib0133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102578","article-title":"Reported high salt intake is associated with increased prevalence of abdominal aortic aneurysm and larger aortic diameter in older men","volume":"9","author":"Golledge","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0134","doi-asserted-by":"crossref","first-page":"j909","DOI":"10.1136\/bmj.j909","article-title":"Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population-based cohort study using linked health records","volume":"356","author":"Bell","year":"2017","journal-title":"BMJ"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0135","first-page":"433","article-title":"Aortic diseases and obstructive sleep apnea","volume":"35","author":"Takagi","year":"2016","journal-title":"Int Angiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0136","first-page":"4991","article-title":"Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study","volume":"56","author":"Gaisl","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0137","first-page":"H19","article-title":"Effects of acute exercise on endothelial function in patients with abdominal aortic aneurysm","volume":"314","author":"Bailey","year":"2018","journal-title":"Am J Physiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0138","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjmed.2020.07.029","article-title":"Effects of exercise training on vascular markers of disease progression in patients with small abdominal aortic aneurysms","volume":"134","author":"Niebauer","year":"2021","journal-title":"Am J Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0139","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/SLA.0000000000001609","article-title":"Preoperative supervised exercise improves outcomes after elective abdominal aortic aneurysm repair: a randomized controlled trial","volume":"264","author":"Barakat","year":"2016","journal-title":"Ann Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0140","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/1741826710389384","article-title":"Cardiopulmonary exercise testing in small abdominal aortic aneurysm: profile, safety, and mortality estimates","volume":"18","author":"Myers","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0141","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/HCR.0b013e3181ebf2db","article-title":"Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial","volume":"30","author":"Myers","year":"2010","journal-title":"J Cardiopulm Rehab Prev"},{"issue":"5","key":"10.1053\/j.semvascsurg.2022.02.007_bib0142","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007959","article-title":"Cardiac rehabilitation protects against the expansion of abdominal aortic aneurysm","volume":"7","author":"Nakayama","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0143","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jvs.2018.07.069","article-title":"Meta-analysis of randomized controlled trials on safety and efficacy of exercise training in patients with abdominal aortic aneurysm","volume":"69","author":"Kato","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0144","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejvs.2014.10.008","article-title":"Beneficial effects of pre-operative exercise therapy in patients with an abdominal aortic aneurysm: a systematic review","volume":"49","author":"Pouwels","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1590\/1677-5449.190086","article-title":"Effectiveness and safety of structured exercise vs. no exercise for asymptomatic aortic aneurysm: systematic review and meta-analysis","volume":"19","author":"Oliveira","year":"2020","journal-title":"J Vasc Bras"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0146","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/HCR.0000000000000521","article-title":"Aortic aneurysm: diagnosis, management, exercise testing, and training","volume":"40","author":"Ehrman","year":"2020","journal-title":"J Cardiopulm Rehab Prev"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0147","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00684","article-title":"Patients awaiting surgical repair for large abdominal aortic aneurysms can exercise at moderate to hard intensities with a low risk of adverse events","volume":"7","author":"Weston","year":"2017","journal-title":"Front Physiology"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0148","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14779072.2019.1585807","article-title":"Exercise and sports participation in patients with thoracic aortic disease: a review","volume":"17","author":"Thijssen","year":"2019","journal-title":"Exp Rev Cardiovasc Ther"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0149","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jvn.2013.05.002","article-title":"Patient recruitment and experiences in a randomised trial of supervised exercise training for individuals with abdominal aortic aneurysm","volume":"32","author":"Gunasekera","year":"2014","journal-title":"J Vasc Nurs"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jvs.2017.12.063","article-title":"Antihypertensive medication adherence in chronic type B aortic dissection is an important consideration in the management debate","volume":"68","author":"Martin","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0151","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/eurheartj\/ehy566.P6256","article-title":"Adherence to prescribed drugs among 65-74 years old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a randomized screening trial","volume":"39","author":"Qvist","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0152","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejvs.2018.09.023","article-title":"Adherence to prescribed drugs among 65-74 year old men diagnosed with abdominal aortic aneurysm or peripheral arterial disease in a screening trial: a VIVA substudy","volume":"57","author":"Qvist","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0153","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejvs.2017.06.018","article-title":"The impact of compliance with imaging follow-up on mortality after endovascular abdominal aortic aneurysm repair: a population based cohort study","volume":"54","author":"de Mestral","year":"2017","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0154","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jvn.2012.08.001","article-title":"Marfan syndrome teaching algorithm: does it make a difference?","volume":"31","author":"Strider","year":"2013","journal-title":"J Vasc Nur"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0155","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jvs.2018.02.029","article-title":"Patient satisfaction with the consent discussion is not improved by showing patients their computed tomography or angiography images before they undergo vascular surgery","volume":"68","author":"LeBlanc","year":"2018","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0156","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bcpt.13459","article-title":"Randomised trial of telephone counselling to improve participants' adherence to prescribed drugs in a vascular screening trial","volume":"127","author":"Qvist","year":"2020","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0157","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/ajmg.a.61827","article-title":"Multidisciplinary aortopathy clinics: a systematic scoping review of the literature and evaluation of patient experiences from a newly started clinic in Norway","volume":"182","author":"Bathen","year":"2020","journal-title":"Am J Med Genet"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0158","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/bjs.10269","article-title":"Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm","volume":"103","author":"Bahia","year":"2016","journal-title":"Br J Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0159","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cjco.2019.03.002","article-title":"Practice variation among Canadian pediatric cardiologists in medical management of dilated ascending aorta in patients with bicuspid aortic valve","volume":"1","author":"Hussain","year":"2019","journal-title":"CJC Open"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.23736\/S0021-9509.18.10129-7","article-title":"Is management of complex abdominal aortic aneurysms consistent? A questionnaire-based survey","volume":"61","author":"Atkins","year":"2020","journal-title":"J Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0161","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/SLA.0000000000000895","article-title":"Preoperative methylprednisolone enhances recovery after endovascular aortic repair: a randomized, double-blind, placebo-controlled clinical trial","volume":"260","author":"de la Motte","year":"2014","journal-title":"Ann Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0162","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1253\/circj.CJ-16-0902","article-title":"Oral steroid use and abdominal aortic aneurysm expansion \u2015 positive association","volume":"81","author":"Tajima","year":"2017","journal-title":"Circ J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0163","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.116.025144","article-title":"Association between aortic dissection and systemic exposure of vascular endothelial growth factor pathway inhibitors in the Japanese adverse drug event report database","volume":"135","author":"Oshima","year":"2017","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0164","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jvs.2014.06.123","article-title":"The effect of chemotherapy for malignancy on the natural history of aortic aneurysm","volume":"61","author":"Martin","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0165","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.avsg.2020.08.137","article-title":"Aortic aneurysm natural progression is not influenced by concomitant malignancy and chemotherapy","volume":"71","author":"Maxwell","year":"2021","journal-title":"Ann Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0166","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.amjmed.2014.05.005","article-title":"Cocaine-related aortic dissection: Lessons from the international registry of acute aortic dissection","volume":"127","author":"Dean","year":"2014","journal-title":"Am J Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0167","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1161\/CIRCULATIONAHA.117.031264","article-title":"Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research","volume":"137","author":"Evangelista","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1053\/j.semvascsurg.2022.02.007_bib0168","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1097\/MJT.0b013e3181ea30eb","article-title":"Cocaine and cardiovascular complications","volume":"18","author":"Bhargava","year":"2011","journal-title":"Am J Ther"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0169","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.tcm.2014.12.013","article-title":"Cardiovascular consequences of cocaine use","volume":"25","author":"Stankowski","year":"2015","journal-title":"Trends Cardiovasc Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2459\/JCM.0000000000000511","article-title":"Cocaine and coronary artery diseases: a systematic review of the literature","volume":"18","author":"Talarico","year":"2017","journal-title":"J Cardiovasc Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0171","doi-asserted-by":"crossref","first-page":"764","DOI":"10.21470\/1678-9741-2020-0333","article-title":"Cocaine-related aortic dissection: what do we know?","volume":"35","author":"Greve","year":"2020","journal-title":"Brazilian J Cardiovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0172","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jvs.2018.10.061","article-title":"Cocaine use is associated with worse outcomes in patients treated with thoracic endovascular repair for type B aortic dissection","volume":"70","author":"Yammine","year":"2019","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0173","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jccase.2016.12.008","article-title":"Ascending aortic dissection in a young patient using a synephrine-containing workout supplement","volume":"15","author":"Doctorian","year":"2017","journal-title":"J Cardiol Cases"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0174","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jocn.2012.04.023","article-title":"Vertebral artery dissection associated with sildenafil abuse","volume":"20","author":"Dersch","year":"2013","journal-title":"J. Clin. Neurosci"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0175","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.5001\/omj.2020.120","article-title":"Anabolic steroid use and aortic dissection in athletes: a case series","volume":"35","author":"Heydari","year":"2020","journal-title":"Oman Med. J"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0176","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/CIRCULATIONAHA.109.886408","article-title":"Randomized comparison of strategies for type B aortic dissection: the INvestigation og STEnt Grafts in Aortic Dissection (INSTEAD) trial","volume":"120","author":"Nienaber","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0177","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jvs.2019.07.084","article-title":"Medical therapy in type B aortic intramural hematoma is associated with a high failure rate","volume":"71","author":"Mesar","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0178","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.amjcard.2011.08.012","article-title":"Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD])","volume":"109","author":"Suzuki","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0179","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jvs.2012.08.064","article-title":"The results of stent graft versus medication therapy for chronic type B dissection","volume":"57","author":"Jia","year":"2013","journal-title":"J. Vasc. Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/1538574413495462","article-title":"Endovascular versus medical therapy for uncomplicated type B aortic dissection: a qualitative review","volume":"47","author":"Merola","year":"2013","journal-title":"Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0181","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.jvs.2014.12.038","article-title":"The natural history of medically managed acute type B aortic dissection","volume":"61","author":"Durham","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0182","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/HCO.0000000000000216","article-title":"Abdominal aortic aneurysm: novel mechanisms and therapies","volume":"30","author":"Davis","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0183","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2174\/1570161115666170413145705","article-title":"Pharmacological therapy of abdominal aortic aneurysm: an update","volume":"16","author":"Wang","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0184","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7213760","article-title":"Modulation of immune-inflammatory responses in abdominal aortic aneurysm: emerging molecular targets","volume":"2018","author":"Li","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0185","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0218492320943350","article-title":"Immunological therapeutics in acute aortic syndrome","volume":"28","author":"Rimmer","year":"2020","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0186","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.ejvs.2020.08.032","article-title":"Blocking interleukin-1 beta reduces the evolution of thoracic aortic dissection in a rodent model","volume":"60","author":"Guo","year":"2020","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0187","article-title":"PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-\u03b2\/\u03b4 and PPAR-\u03b3","volume":"13","author":"Han","year":"2017","journal-title":"Future Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0188","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.semvascsurg.2012.03.004","article-title":"Can pharmacologic agents slow abdominal aortic aneurysm growth?","volume":"25","author":"Samson","year":"2012","journal-title":"Semin Vasc Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0189","doi-asserted-by":"crossref","first-page":"314","DOI":"10.2174\/1570161111311030006","article-title":"Mast cells in abdominal aortic aneurysms","volume":"11","author":"Shi","year":"2013","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0190","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/ATVBAHA.110.213157","article-title":"Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms","volume":"31","author":"Swedenborg","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0191","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3390\/ijms17081312","article-title":"The potential role of kallistatin in the development of abdominal aortic aneurysm","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0192","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/eci.12103","article-title":"Potential role for anti-angiogenic therapy in abdominal aortic aneurysms","volume":"43","author":"Vijaynagar","year":"2013","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0193","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/jocs.14512","article-title":"Aortic morphology post type A acute aortic syndrome: prognosis significance and association with 24-hour blood pressure-monitoring parameters","volume":"35","author":"Delsart","year":"2020","journal-title":"J Cardiac Surg"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0194","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1161\/ATVBAHA.121.315715","article-title":"Deletion of AT1a (angiotensin II type 1a) receptor of inhibition of angiotensinogen synthesis attenuates thoracic aortopathies in fibrillin 1C1041G\/+ mice","volume":"41","author":"Chen","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s13311-018-0670-z","article-title":"Statin-associated muscle disease: advances in diagnosis and management","volume":"15","author":"Taylor","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0196","doi-asserted-by":"crossref","first-page":"17958","DOI":"10.1038\/s41598-019-53238-7","article-title":"Statin treatment increases the clinical risk of tendinopathy through matrix metalloproteinase release \u2013 a cohort study design combined with an experimental study","volume":"9","author":"Eliasson","year":"2019","journal-title":"Sci Rep"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0197","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0198","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5694\/mja15.00806","article-title":"Statins and tendinopathy: a systematic review","volume":"204","author":"Teichtahl","year":"2016","journal-title":"Med J Aust"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0199","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semvascsurg.2022.02.007_bib0200","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.surg.2018.06.036","article-title":"Tamsulosin attenuates abdominal aortic aneurysm growth","volume":"164","author":"Montgomery","year":"2018","journal-title":"Surgery"}],"container-title":["Seminars in Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895796722000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T05:38:12Z","timestamp":1760247492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895796722000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0895796722000072"],"URL":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.02.007","relation":{},"ISSN":["0895-7967"],"issn-type":[{"value":"0895-7967","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An assessment of the current medical management of thoracic aortic disease: A patient-centered scoping literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semvascsurg.2022.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}